Treatment-Related Amenorrhea With T-Dm1 Plus Pertuzumab (Kp) Is Lower Than With Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (Tchp) In The Phase Iii Neoadjuvant Kristine Trial

CANCER RESEARCH(2021)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要